Pre-clinical diastolic dysfunction

Siu Hin Wan, Mark W. Vogel, Horng H. Chen

Research output: Contribution to journalReview articlepeer-review

185 Scopus citations


Pre-clinical diastolic dysfunction (PDD) has been broadly defined as left ventricular diastolic dysfunction without the diagnosis of congestive heart failure (HF) and with normal systolic function. PDD is an entity that remains poorly understood, yet has definite clinical significance. Although few original studies have focused on PDD, it has been shown that PDD is prevalent, and that there is a clear progression from PDD to symptomatic HF including dyspnea, edema, and fatigue. In diabetic patients and in patients with coronary artery disease or hypertension, it has been shown that patients with PDD have a significantly higher risk of progression to heart failure and death compared with patients without PDD. Because of these findings and the increasing prevalence of the heart failure epidemic, it is clear that an understanding of PDD is essential to decreasing patients' morbidity and mortality. This review will focus on what is known concerning pre-clinical diastolic dysfunction, including definitions, staging, epidemiology, pathophysiology, and the natural history of the disease. In addition, given the paucity of trials focused on PDD treatment, studies targeting risk factors associated with the development of PDD and therapeutic trials for heart failure with preserved ejection fraction will be reviewed.

Original languageEnglish (US)
Pages (from-to)407-416
Number of pages10
JournalJournal of the American College of Cardiology
Issue number5
StatePublished - Feb 11 2014


  • diastolic dysfunction
  • echocardiography
  • heart failure epidemiology
  • heart failure treatment
  • heart failure with preserved ejection fraction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Pre-clinical diastolic dysfunction'. Together they form a unique fingerprint.

Cite this